Lorena Lerner's most recent trade in Keros Therapeutics Inc was a trade of 75,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | Lorena Lerner | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 75,000 | 75,000 | - | - | Employee Stock Option (Right to Buy) | |
| Keros Therapeutics Inc | Lorena Lerner | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 16.35 per share. | 18 Feb 2026 | 3,873 | 31,127 | - | 16.4 | 63,324 | Common Stock |